a therapeutically important target. GR ligands, including dexamethasone, prednisolone, and other related corticosteroid analogs, are commonly used to treat diverse medical conditions such as asthma, allergic rhinitis, rheumatoid arthritis, and leukemia (Barnes et al., 1998). structures not only reveal that the LBDs fold into a ca-9 These authors contributed equally to this work.
, is
Dexamethasone is a potent agonist that promotes the defective in transcription activation but not transrepresbinding of coactivators to GR (Ding et al., 1998). To sion (Reichardt et al., 1998) .
test the ability of the dexamethasone-bound GR LBD Given its biological and pharmaceutical importance, to recruit coactivators, we used surface plasmon resothere has been enormous interest in elucidating the GR nance to measure the interaction of the receptor with LBD structure. However, these structural efforts have a peptide containing the third LXXLL motif from TIF2 been hampered by the inability to obtain a purified re- (Voegel et al., 1998) . TIF2 is the human homolog of the ceptor that retains ligand binding activity. In this paper, mouse GR interacting protein 1 (GRIP1) and its third we describe expression, purification, crystallization, and LXXLL motif has been shown to be preferred by GR structure determination of the GR LBD in complex with (Ding et al., 1998). Figure 1C shows that addition of a dexamethasone and a coactivator motif derived from the cofactor TIF2. Surprisingly, the structure reveals a novel 5-fold excess of dexamethasone enhances the binding Helilyzed GR LBD. In contrast, addition of a 5-fold excess of RU486, a known GR antagonist, inhibited the binding ces 1 and 3 form one side of a helical sandwich whereas helices 7 and 10 form the other side. The middle layer of the receptor to the TIF2 peptide. These results demonstrate that the purified GR LBD is able to bind either of helices (helices 4, 5, 8, and 9) are present in the top half of the protein but are absent in the bottom half of an agonist or an antagonist in the absence of the hsp90 chaperone. Importantly, the ligand-mediated associathe protein. This arrangement of helices creates a cavity in the bottom half of the GR LBD where the dexamethation of the TIF2 peptide to the purified GR correlates with the agonist and antagonist properties of dexamethsone molecule is bound. The AF-2 helix, which plays an essential function in ligand-dependent activation, adopts asone and RU486. Based on these results, a ternary complex of the purified GR LBD bound with dexamethathe so-called "agonist bound" conformation where it packs against helices 3, 4, and 10 as an integrated part sone and the TIF2 peptide was prepared and crystallized ( Figure 1D ). of the domain structure. Following the AF-2 helix is an the extended strand between helices 1 and 3 (residues 547-551) and the last residue of helix 5 (Q615). In particuextended strand that forms a conserved ␤ sheet with a ␤ strand between helices 8 and 9. This C-terminal ␤ lar, residues 547-551 from each LBD, resembling two anti-parallel ␤ strands, are in excellent geometry to form strand also appears to play an important role in receptor activation by stabilizing the AF-2 helix in the active confour hydrogen bonds ( Figure 3C ). These hydrogen bonds may also play a key role in stabilizing the GR dimer formation. Deletion of the last few residues that form the ␤ strand resulted in an inactive receptor (Zhang et configuration.
To confirm the presence of dimeric GR LBD in solual., 1996). tion, we analyzed the distribution of monomers and dimers in the GR population by equilibrium analytical ultraThe GR Dimer Interface Strikingly, the two GR LBD monomers in each asymmetcentrifugation. In the presence of both dexamethasone and the TIF2 peptide, a clear monomer-dimer equilibric unit are arranged in a unique dimer configuration. Unlike the asymmetric arrangement of the PPAR␥/RXR rium was observed with an apparent dimerization affinity (Kd) of 1.5 M ( Figure 4A ). We further confirmed the heterodimer structures (Gampe et al., 2000), the two GR monomers show a C2 symmetric packing arrangement presence of the GR dimer in solution by dynamic light scattering. In this experiment, the PPAR␥/RXR heteroin which either LBD can be superimposed on the other by rotating 180 degrees around the 2-fold axis (Figure dimer was used as a positive control with a measured hydrodynamic diameter of 84 Å , which is consistent with 2A). Formation of the dimer buries 623 Å 2 of solvent accessible surface in the dimer interface, which is also the actual size of the heterodimer observed in PPAR␥/ RXR crystal structure (Gampe et al., 2000). The hydrodystabilized by a series of hydrophobic and hydrogen bond interactions ( Figure 3A) . The central hydrophobic internamic diameter of the GR LBD complex was measured to be 82 Å , which is also closely correlated with the side face is made up of reciprocal interactions between residues P625 and I628 in the ␤ turn of strands 3 and 4 to side distance of 83-88 Å observed in the GR dimer structure. (Figure 3B ). Surrounding this core hydrophobic interface is an extensive network of hydrogen bonds mediated by Since P625 and I628 make up the core hydrophobic dimer interface, these residues were mutated to alanine within the context of the F602S mutant to test their role in LBD-LBD dimerization. The P625A/F602S LBD protein was insoluble in E. coli and was not useful for biochemical studies. However, the I628A/F602S GR LBD is nearly as soluble as the F602S LBD ( Figure 4B ) and was purified to homogeneity for in vitro characterization (lane 7 in Figure 4B ). As measured by analytical ultra-centrifugation, the I628A/F602S mutant LBD showed a 10-fold decrease in dimerization affinity as compared to the F602S GR LBD ( Figure 4A ). These results demonstrate fold activation, respectively ( Figure 4C ). The P625A and I628A mutant proteins were expressed at levels comparable to wild-type (Western blot in Figure 4D ), but both showed a 3-to 5-fold decrease in fold of activation as activation by NF-B. In this assay, we used a reporter driven by the promoter from the monocyte chemoattraccompared with the wild-type. Furthermore, the absolute magnitude of activation by the P625A mutant is only 5% tant protein-1 (MCP-1), which is a well-characterized NF-B activated gene (Ping et al., 1999) . In contrast to of wild-type. The results with the P625A mutant are consistent with a previous study where the analogous the transactivation assay, GR with the I628A mutation repressed the MCP-1 promoter activity to the same exrat GR mutant (P643A) was also defective in transactivation (Caamano et al., 1998). Together, these results estent as the wild-type or the F602S receptor ( Figure 4C ). However, the P625A mutant was inactive in this assay. tablish that residues comprising the dimer interface are important for the GR transactivation function.
This defect in activity of the P625A mutant in both assays is consistent with previous studies that indicated that We also tested the ability of the GR mutants to inhibit the analogous rat mutation (P643A) did not translocate bonds between the second GR charge clamp and the TIF2 coactivator by mutating the residues at the ϩ2 properly to the nucleus in the presence of ligand (Caand ϩ6 positions of the third LXXLL motif. Replacing amano et al., 1998). Importantly, the contrasting effects these two residues in the third motif with corresponding of I628A on transactivation versus transrepression sugresidues from the second motif decreased binding to gest that the monomer and dimer forms of GR may GR ( Figure 5D ). Therefore, the hydrogen bonds formed regulate distinct signaling pathways.
with the second charge clamp contribute to the selective binding of the third TIF2 LXXLL motif. We also directly Recognition of the TIF2 LXXLL Motif addressed the role of the second charge clamp by muCoactivators such as SRC-1 and TIF2 contain three tating the two charged residues D590 and R585 to ala-LXXLL motifs, and all previous crystal structures of LBD/ nine within the context of a GAL4-GR LBD chimeric coactivator complexes were solved with the first or the receptor. The fusion protein of the wild-type GR LBD second LXXLL motif. The GR LBD/TIF2 complex is the with the GAL4-DBD induced 5-fold activation of the refirst structure with the third LXXLL motif, and it provides porter driven by the GAL4 DNA binding sites ( Figure 5E ). an unexpected explanation for the preferential binding Mutations either in the first charge clamp (E755 on the of this motif to the receptor (Ding et al., 1998). In the AF-2 helix) or the second charge clamp (residues R585 GR LBD structure, the LLRYLL sequence in the TIF2 and D590) dramatically reduced the activation mediated motif forms a two-turn ␣ helix that orients the hydrophoby the GR LBD, demonstrating that both charge clamps bic leucine side chains into a groove formed in part by are critical for transactivation in vivo. the AF-2 helix and residues from helices 3, 3Ј, 4 , and 5
The residues (D590 and R585) comprising the second ( 
2B). The ligand binding pocket is composed of residues
observed here are likely to contribute to the high affinity binding of dexamethasone. from helices 3, 4, 5, 6, 7, 10, and the AF-2 helix as well as residues from the ␤ strands 1 and 2. Strikingly, Interestingly, dexamethasone also makes direct contacts with the AF-2 helix (L753) and the loop preceding compared with the steroid-shaped pocket found in the PR, AR, or ER structures, the GR pocket has an addithe AF-2 helix (residues I747 and F749). These interactions are likely to stabilize the AF-2 helix in the active tional branch extending from the center in the side of the steroid pocket. This additional side pocket in GR is conformation, and may serve as a molecular basis for ligand-dependent activation of GR. formed by the structural rearrangement of helices 6 and 7 ( Figure 6A) .
The binding mode of dexamethasone can be deterDiscussion mined unambiguously by the clear electron density (Figure 6B) . The ligand is oriented with its A ring toward the A longstanding problem for GR structural studies has been the expression and purification of an active protein. ␤ strands 1 and 2 and its D-ring toward the AF-2 helix. The volume of the GR pocket is approximately 599 Å 3 Here, we have overcome this problem by using a single point mutation, F602S, in the GR LBD. This single mutain subunit A and 578 Å 3 in subunit B. Although dexamethasone occupies only 65% of the volume, the high affinity tion resulted in robust expression of a soluble GR LBD and ultimately allowed us to solve its crystal structure. binding of dexamethasone to GR is readily explained by the extensive hydrophobic and hydrophilic interactions
The structure revealed a novel dimer interface, a unique steroid binding pocket, and a second charge clamp rebetween the ligand and the protein ( Figure 6C) . One or more hydrophobic residues within the GR protein sponsible for sequence specific binding of a coactivator protein. These structural observations provide critical contact nearly every atom of the steroid core of dexamethasone.
insights into the protein-ligand and protein-protein interactions that control the GR signaling pathways. In addition, all of the hydrophilic groups of dexamethasone form hydrogen bonds with the protein. As shown in Figure 6C , the A ring carbonyl forms direct hydrogen Important Role of the GR Dimer The GR LBD in the crystal is packed as a symmetric bonds to the guanidinium of R611 and to the ␥-amide of Q570. The side chain of N564 is oriented in a way to allow dimer, which is consistent with biochemical data showing that the GR LBD can form a homodimer or a heteroit to make hydrogen bonds to the C ring 11-hydroxyl and 24-hydroxyl. Furthermore, the 21-hydroxyl (off the dimer with the closely related MR LBD. These earlier studies, however, failed to identify the position or the C17 position) and the 22-carbonyl form hydrogen bonds with residues Q642 and T739, respectively. The extenconfiguration of the GR dimer interface (Savory et al.,  2001 ). The crystallographically observed GR LBD dimer sive hydrogen bond network between GR and the ligand interface is strikingly different from the helix-10 dimer ous study in which the rat GR with the corresponding interface observed in the previous ER homodimer or mutation P643A was defective in transactivation (Ca-RXR heterodimer structures. Structure based sequence amano et al., 1998). Although the P643A rat GR retained alignments reveal that RXR and its heterodimer partners normal ability to bind DNA, it showed decreased stability have a consensus dimerization motif of φ AKφφ φKφφ for heterocomplex formation with hsp90. Since P625 is X φRφφ that forms a coiled-coil structure in the first the central dimerization residue, this would suggest that half of H10 (Gampe et al., 2000) . ER and HNF4 have the the GR dimerization interface might overlap the hsp90 same φXφφ repeats that allow them to form homodibinding site. mers but lack the basic residues in the X position reCompared with the large interface observed in the quired for heterodimerization. However, GR and its re-RXR dimer structures, the GR LBD dimerization interlated receptors, PR and AR, have a sequence of F YQLT face is much more limited, reflecting its weaker dimer-KLLD S MHEV in the corresponding H10 region that is ization affinity (Kd ‫5.1ف‬ M for GR versus ‫01ف1‬ nM for not able to form a coiled-coil structure due to the devia-RXR dimers). In the context of the full-length receptor, tion of the underlined residues from the φXφφ repeats.
the low dimerization affinity of the GR LBD can be comFurthermore, in the GR structure, the extended C-ter- structure reveals that GR uses two charge clamps to The GR LBD contains multiple functions including lidefine its sequence specific binding to the TIF2 third gand binding, chaperone association, nuclear location, motif. The first charge clamp is composed of E755 from transcription regulation, and others. These functions are the AF-2 helix and K579 from helix-3, which cap the interconnected and are highly dependent on the integbackbone amides and carbonyls of the coactivator helix. rity of the three-dimensional structure of the LBD. It is Both residues that form the first charge clamp are highly possible that the phenotype of the I628A mutant can be conserved across members of the NR superfamily and attributed to other functions of the LBD in addition to dictate a common binding mode for all LXXLL motifs. its effect on dimerization. We have found that the I628A
The second charge clamp is composed of R585 and mutant LBD requires a 20-fold higher concentration of D590, which form hydrogen bonds with the side chains dexamethasone to achieve full activation as compared of the residues Rϩ2 and Dϩ6 that are present in the to the wild-type receptor (data not shown). However, TIF2 third motif but not in its first or second motif. These the I628A mutant is still competent for nuclear localizainteractions with the second charge clamp are responsition and transrepression function at the same ligand ble, in part, for the binding specificity of GR for the TIF2 concentration used for activation of the wild-type recepthird motif. Our results are consistent with the observator. Thus, a mutation in the dimer interface can selection that the binding specificity of this motif is encomtively decrease the potency for transactivation by the passed within the TIF2 sequence of KENALLRYLLDKDD GR LBD.
(Darimont et al., 1998). The residues from the second The different phenotypes of the I628A and P625A mucharge clamp are conserved in the oxosteroid receptors tants may be attributed, in part, to the behavior of their GR, AR, PR, and MR but are not present in ER or RXRproteins. P625 is located in the ␤-turn between two ␤ obligate heterodimers, such as PPAR. Thus, the second strands and is conserved among steroid receptors. It is charge clamp may account for the differential binding of likely that the P625A mutation disrupts the ␤-turn, thus coactivator motifs by many nuclear receptors. Notably, reducing the protein stability. Although in vivo, expresonly the second LXXLL motif is required to mediate ER sion of the full-length receptor either with I628A or transactivation while PPAR␥ requires both the first and P625A appears to be similar (Figure 4D) , the P625A the second motifs. Since proteins like SRC-1 and TIF2 mutant LBD is much less soluble than the I628A mutant function as promiscuous coactivators, the existence of in E. coli ( Figure 4B) . The P625A mutant also shows three LXXLL motifs within their sequence may allow defects in nuclear translocation upon ligand binding (data not shown). Our results are consistent with a previthem to integrate signaling pathways across multiple 
NRs. Alternatively, as yet undiscovered coactivators
The selectivity of GR ligands with larger substituents at the C17 position can be best explained by the larger may exist that modulate GR signal transduction through selective interactions with the second charge clamp.
GR-side pocket. However, as discussed above, MR presumably has a similar pocket to GR. The selectivity of MR for mineralocorticoids can be attributed to the differHormone Selectivity by Steroid Receptors Endogenous steroid hormones such as cortisone, tesences in hydrogen bonding patterns between the receptor and the ligands. In fact, the MR selective steroids, tosterone, or progesterone share a similar core chemical structure ( Figure 6D ) but mediate distinct biological recorticosterone, aldosterone, and 11-deoxylcorticosterone, all lack the 17␣-hydroxyl group, which forms a sponses. Structural comparisons of GR, AR, PR, and ER have provided insight into how functional specificity specific hydrogen bond with Q642 in the GR structure. At this position, MR has a hydrophobic leucine (L848) is achieved by the steroid receptors. These steroid receptors share over 50% identity in their amino acid sethat would disfavor the presence of a polar hydroxyl in this region. Together, the steroid selectivity appears to quences and a similar three-dimensional structure. In these structures, the core steroid template (A, B, C, and be achieved by the complementarity of shape and hydrogen bonding between ligands and the ligand binding D rings) assumes a common orientation with the A ring oriented toward the conserved arginine from helix-5 and pockets in the receptors the D ring toward the AF-2 helix. However, many subtle differences in the secondary structure and the topology Naturally Occurring Mutations in the GR LBD Missense mutations in the GR LBD have been associof the ligand binding pockets exist in these steroid receptors. In particular, helices 6 and 7 of GR deviate ated with a number of diseases, such as Cushing's syndrome, autoimmune diseases, and various cancers, and significantly from ER, AR, and PR and produce a unique side pocket in GR ( Figure 6A ). This pocket may account the impact of these mutations can readily be explained by our structure. Based on the location in the GR strucfor the GR selectivity of glucocorticoids, which have larger substituents at the C17␣ position compared with ture ( Figure 7A ), these mutations can be classified into two groups. The first group includes the mutations estrogen, progesterone, and testosterone ( Figure 6D) . Interestingly, the mineralocorticoids that selectively G507C, M601L, M604P, M646T, Y735S, C736S, and L753F. In the structure, these residues are found to make bind MR have similar substituents at the C17␣ position. MR may also have a similar pocket for these large C17␣ direct contacts with dexamethasone (green balls, Figure  7A ), and their mutations most likely result in a GR molesubstitutes, since the residues that form the GR side pocket are also conserved in MR.
cule that is defective in ligand binding. The second group includes mutations of P541A, I559D, C638Y, V729I, Besides the shape differences, the polar atoms are also distributed differently in the steroid pockets with Y764N, and F774A (white balls, Figure 7A ). In the structure, these residues are involved in hydrophobic interacrespect to the specific protein-ligand hydrogen bonds. For example, the polar substituents in steroid hormones tions within the protein, and their mutations may therefore destabilize the protein. The availability of the GR are mainly located at positions C3 or C17. In the GR structure, the C3 ketone accepts hydrogen bonds from structure provides an opportunity to determine whether there is any correlation in the locations of these muta-Q570 and R611, which are also conserved in AR and PR. In ER, the glutamine is replaced by glutamate, which tions with the clinical phenotypes. prefers to accept a hydrogen bond from the ligand, therefore accounting for ER's selectivity of a hydroxyl Structural Basis for the Improvement of Protein Solubility by the F602S Mutation group at the C3 position. These differences in hydrogen bond formation may explain why GR, as well as AR, PR, It is intriguing that a single point mutation of F602S has such a dramatic impact on the solubility of the GR LBD. and MR prefer the steroid hormones with a ketone at the C3 position, whereas ER prefers a hydroxyl group.
The F602S mutation was one of fourteen mutations that were suggested by sequence alignment and analysis and/or exchange in vivo is dependent on hsp90. Moreof a GR homology model. Most of the mutations were over, the hsp90 complex may also function to prevent targeted for lipophilic residues exposed on the surface the wild-type GR protein from aggregating in vivo by of the protein, but had little or no effect on expression maintaining the structural integrity of the otherwise unor solubility. In contrast, F602 was identified as a buried, stable protein. lipophilic residue that appeared to fit poorly into its environment within GR. Remarkably, the F602S mutation specific volume of the protein, , was calculated as described (Cohn and Edsall, 1943) . Adjustments for temperature were made using summarized in Table 1 . The 2-fold symmetry axis of the GR dimer was calculated as axis of the rotation that would superimpose one the appropriate equation that has been modified to use values derived for each amino acid at 25ЊC (Durchschlag, 1986) . The partial LBD onto the other. The superposition was carried out using the C␣ atoms from residues 530-777 of GR. Solvent accessible surface specific volume of GR LBD was calculated to be 0.736 mL/g at 4ЊC.
Runs were performed at 17,500, 20,000, 22,500, and 25,000 rpm at areas were calculated with the Connolly MS program and the MVP program (Connolly, 1983 
